Paolo Polucci

1.3k total citations
26 papers, 678 citations indexed

About

Paolo Polucci is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Paolo Polucci has authored 26 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 18 papers in Organic Chemistry and 9 papers in Toxicology. Recurrent topics in Paolo Polucci's work include Cancer therapeutics and mechanisms (15 papers), Synthesis and Biological Evaluation (12 papers) and Bioactive Compounds and Antitumor Agents (9 papers). Paolo Polucci is often cited by papers focused on Cancer therapeutics and mechanisms (15 papers), Synthesis and Biological Evaluation (12 papers) and Bioactive Compounds and Antitumor Agents (9 papers). Paolo Polucci collaborates with scholars based in Italy, United Kingdom and Poland. Paolo Polucci's co-authors include Ippolito Antonini, Sante Martelli, Lloyd R. Kèlland, Stephen Neidle, Nicoletta Pescalli, Terence C. Jenkins, Ernesto Menta, Anthony P. Reszka, Sharon Gowan and Philip J Perry and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Paolo Polucci

26 papers receiving 661 citations

Peers

Paolo Polucci
Mauro Marzi Italy
Bruce Follows United States
Maria Ornella Tinti Italy
Hea‐Young Park Choo South Korea
M. Naseer A. Khan India
Zhengxiang Gu United States
David J. Madar United States
Annalina Lapucci Italy
Brian M. Fox United States
Toshiharu Yoshino Japan
Mauro Marzi Italy
Paolo Polucci
Citations per year, relative to Paolo Polucci Paolo Polucci (= 1×) peers Mauro Marzi

Countries citing papers authored by Paolo Polucci

Since Specialization
Citations

This map shows the geographic impact of Paolo Polucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Polucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Polucci more than expected).

Fields of papers citing papers by Paolo Polucci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Polucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Polucci. The network helps show where Paolo Polucci may publish in the future.

Co-authorship network of co-authors of Paolo Polucci

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Polucci. A scholar is included among the top collaborators of Paolo Polucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Polucci. Paolo Polucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ardini, Elena, Patrizia Banfi, Nilla Avanzi, et al.. (2018). Abstract 4785: NMS-E668, a highly potent orally available RET inhibitor with selectivity towards VEGFR2 and demonstrated antitumor efficacy in multiple RET-driven cancer models. Cancer Research. 78(13_Supplement). 4785–4785. 2 indexed citations
2.
Casale, Elena, Nadia Amboldi, Maria Gabriella Brasca, et al.. (2014). Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitors. Bioorganic & Medicinal Chemistry. 22(15). 4135–4150. 34 indexed citations
3.
4.
Antonini, Ippolito, et al.. (2004). Rational design, synthesis and biological evaluation of 3H-naphtho[1,2,3-de]quinoline-2,7-diones: a new class of potential antitumor agents. Polish Journal of Chemistry. 78(8). 1019–1025. 2 indexed citations
5.
Antonini, Ippolito, et al.. (2004). Rational Design, Synthesis, and Biological Evaluation of Bis(pyrimido[5,6,1-de]acridines) and Bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as New Anticancer Agents. Journal of Medicinal Chemistry. 47(21). 5244–5250. 43 indexed citations
6.
7.
Antonini, Ippolito, et al.. (2003). Rational design, synthesis and biological evaluation of thiadiazinoacridines: A new class of antitumor agents. Bioorganic & Medicinal Chemistry. 11(3). 399–405. 24 indexed citations
8.
Bagiński, Maciej, Paolo Polucci, Ippolito Antonini, & Sante Martelli. (2002). Binding free energy of selected anticancer compounds to DNA - theoretical calculations. Journal of Molecular Modeling. 8(1). 24–32. 17 indexed citations
9.
Antonini, Ippolito, Paolo Polucci, Barbara Gatto, et al.. (2001). 2,6-Di(ω-aminoalkyl)-2,5,6,7-tetrahydropyrazolo[3,4,5-mn]pyrimido[5,6,1-de]acridine-5,7-diones:  Novel, Potent, Cytotoxic, and DNA-Binding Agents. Journal of Medicinal Chemistry. 45(3). 696–702. 18 indexed citations
10.
Antonini, Ippolito, Paolo Polucci, Lloyd R. Kèlland, et al.. (2000). N4-(ω-Aminoalkyl)-1-[(ω-aminoalkyl)amino]-4-acridinecarboxamides:  Novel, Potent, Cytotoxic, and DNA-Binding Agents. Journal of Medicinal Chemistry. 43(25). 4801–4805. 17 indexed citations
11.
Antonini, Ippolito, Paolo Polucci, & Sante Martelli. (1999). Pyrimido[4,5,6-kl]acridines. Synthesis, in vitro cytotoxicity and structure-activity relationships.. PubMed. 14(5). 451–9. 3 indexed citations
12.
Antonini, Ippolito, Paolo Polucci, Lloyd R. Kèlland, et al.. (1999). 2,3-Dihydro-1H,7H-pyrimido[5,6,1-de]acridine-1,3,7-trione Derivatives, a Class of Cytotoxic Agents Active on Multidrug-Resistant Cell Lines:  Synthesis, Biological Evaluation, and Structure−Activity Relationships. Journal of Medicinal Chemistry. 42(14). 2535–2541. 60 indexed citations
13.
14.
Perry, Philip J, Sharon Gowan, Anthony P. Reszka, et al.. (1998). 1,4- and 2,6-Disubstituted Amidoanthracene-9,10-dione Derivatives as Inhibitors of Human Telomerase. Journal of Medicinal Chemistry. 41(17). 3253–3260. 138 indexed citations
15.
Antonini, Ippolito, Paolo Polucci, Terence C. Jenkins, et al.. (1997). 1-[(ω-Aminoalkyl)amino]-4-[N-(ω-aminoalkyl)carbamoyl]-9-oxo-9,10-dihydro- acridines as Intercalating Cytotoxic Agents:  Synthesis, DNA Binding, and Biological Evaluation. Journal of Medicinal Chemistry. 40(23). 3749–3755. 44 indexed citations
16.
Antonini, Ippolito, Paolo Polucci, Maria M. Bontemps‐Gracz, et al.. (1996). Pyrimido [4,5,6-kl] acridines, a new class of potential anticancer agents. Synthesis and biological evaluation.. PubMed. 11(4). 339–49. 7 indexed citations
17.
Antonini, Ippolito, et al.. (1996). Synthesis and biological evaluation of mono- and bis-[(alkylamino)alkylamino] substituted thienopyridopyridazines, a new class of potential antitumor agents.. PubMed. 51(1). 41–7. 1 indexed citations
18.
Antonini, Ippolito, et al.. (1995). Synthesis of (Dialkylamino)alkyl-Disubstituted Pyrimido[5,6,1-de]acridines, a Novel Group of Anticancer Agents Active on a Multidrug Resistant Cell Line. Journal of Medicinal Chemistry. 38(17). 3282–3286. 27 indexed citations
19.
20.
Antonini, Ippolito, et al.. (1993). Synthesis of 9,10-anthraquinone monoalkylaminoalkylhydrazones as potential antitumor drugs.. PubMed. 48(12). 1641–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mauro Marzi Breakdown of academic impact, for papers by Bruce Follows Breakdown of academic impact, for papers by Maria Ornella Tinti Breakdown of academic impact, for papers by Hea‐Young Park Choo Breakdown of academic impact, for papers by M. Naseer A. Khan Breakdown of academic impact, for papers by Zhengxiang Gu Breakdown of academic impact, for papers by David J. Madar Breakdown of academic impact, for papers by Annalina Lapucci Breakdown of academic impact, for papers by Brian M. Fox Breakdown of academic impact, for papers by Toshiharu Yoshino
Rankless by CCL
2026